Environmental consultant AEA Technology rose after reporting a 13% rise in adjusted pre-tax profits to £10.6m in the year ended March."With a new pension deal and much stronger cash generation, the AEA Group is now well positioned for growth," said chief executive Andrew McCree.Drug giant AstraZeneca reported broadly positive results from a US Food and Drug Administration review of the use of the bipolar disorder treatment Seroquel in children and teenagers. Asked whether Seroquel had been shown to be effective for the treatment of schizophrenia in paediatric patients aged between 13 and 17, 17 members of an advisory committee said it had while one member said it had not. While 16 members said Seroquel been shown to be acceptably safe for the treatment of schizophrenia in paediatric patients of that age range, two abstained. Asked whether Seroquel been shown to be effective for the treatment of bipolar mania in paediatric patients aged between 10 and 17, 17 said yes and one abstained. Thirteen members said the treatment had been shown to be acceptably safe for the treatment on bipolar mania, but five abstained.FTSE TechMARK - RisersPuricore (PURI) 14.00p +3.70%GB Group (GBG) 24.00p +3.23%Trafficmaster (TFC) 32.00p +3.23%Innovation Group (TIG) 10.25p +3.02%Phoenix IT Group (PNX) 211.75p +2.92%AEA Technology (AAT) 22.75p +2.25%Imagination Technologies (IMG) 86.75p +2.06%Parity Group (PTY) 14.00p +1.82%Ark Therapeutics (AKT) 46.25p +1.65%Ricardo Group (RCDO) 203.00p +1.50%FTSE TechMARK - FallersInion (IIN) 0.50p -16.67%Optos (OPTS) 62.50p -9.42%E2V Technologies (E2V) 66.00p -4.35%Gresham Computing (GHT) 43.00p -3.37%Wolfson Microelectronics (WLF) 108.50p -3.12%Oxford Biomedica (OXB) 12.00p -2.04%Anite Group (AIE) 37.50p -1.96%ProStrakan (PSK) 90.00p -1.10%Biocompatibles International (BII) 193.00p -1.03%Psion (PON) 55.00p -0.90%